On December 17, Hugui Technology (Chongqing) Co., Ltd. (hereinafter referred to as Hugui Technology) and TRSD Capital successfully launched a roadshow exchange meeting on the medical and biotechnology projects on the 29th floor of the Shanghai Tower.
During the meeting, Mr. Guo Jiayong, the co-founder and CEO of Hugui Technology Co., Ltd., focused on the “Medical Device Registrant System”, “Clinical Trial Reform”, “Local OEM Production”, and “Quality Number License” recently promoted by the mainland. “Applications” and other topics were introduced in detail, and it was emphasized that Hugui ’s medical devices focus on product safety and effectiveness, from product design and development, testing, trial production, quality inspection, clinical trials, production, and sales. Are regulated by China’s NMPA.
